Table 2.

Multivariate Logistic Model Identifying Physician Factors Associated with Screening for Liver Cancer (n = 348)*

	Screen for liver cancer odds ratio (95% confidence interval)
Age, 5-year increments	1.00 (0.97, 1.04)
Male sex (female = reference category [ref.])	0.73 (0.34, 1.58)
Asian race (non-Asian = ref.)	1.08 (0.48, 2.42)
Birthplace in U.S.	0.56 (0.25, 1.26)
Medical specialty (general internal medicine = ref.)
Family practice	0.99 (0.44, 2.21)
Nephrology	0.39 (0.07, 2.13)
Primary medical practice (private = ref.)
University	1.48 (0.58, 3.76)
Health Maintenance Organization (HMO)	3.18 (0.96, 10.57)
Other	0.99 (0.24, 4.05)
Asian Americans have a lower prevalence of chronic hepatitis B compared to Whites†	0.74 (0.54, 1.01)
Screening for liver cancer among high-risk patients reduces liver cancer mortality	1.60 (1.09, 2.34)
Not screening for liver cancer among high-risk patients is a malpractice risk	1.88 (1.29, 2.75)
Would order a cancer screening test if it is a quality of care measure	4.39 (1.79, 10.81)

Model characteristics: R-square = 0.271; Hosmer–Lemeshow goodness-of-fit p value = 0.546

*Excludes gastroenterologists since 100% screened for liver cancer

^†Incorrect answer